QDEL Archives

QDEL

Letters With This Ticker

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Keywords/Themes	Theme Commentary	Pitches	Letter
2025 Q2	Aug 2, 2025	Meridian Contrarian Fund	16.4%	-	AXS, BEPC, BWXT, CCJ, DLTR, FCNCA, HNST, MIR, NVTS, PACK, PRGO, QDEL, SG	Automation, contrarian, nuclear, semiconductors, small cap, turnaround, value	Nuclear power is experiencing a structural turnaround with growing interest from governments, utilities, and major technology firms. The fund holds positions in Cameco Corp and BWX Technologies, both benefiting from the nuclear renaissance driven by uranium supply deficits and new reactor construction including small modular reactors.	QDEL PACK SG NVTS BWXT CCJ QDEL PACK SG NVTS BWXT CCO CN	View
2026 Q1	May 5, 2026	Baron Asset Fund	-7.9%	-7.9%	ACGL, CSGP, GWRE, IDXX, IT, MORN, QDEL, TECH, VEEV, VMC, VRT	AI, Data centers, industrials, infrastructure, mid cap, software, Space, technology		GWRE IT CSGP VRT	View
2026 Q1	May 11, 2026	McIntyre Partnerships	-19.8%	-19.8%	CC, FTRE, ICLR, MDRX, QDEL, SEG, SHC, STHO, SWIM	Concentration, Diagnostics, healthcare, Life Sciences, Medical Devices, small cap, value		QDEL	View
2025 Q1	Apr 30, 2025	Invesco Small Cap Value Fund	-14.6%	-14.6%	AVTR, CCK, IART, ICLR, NRG, QDEL	healthcare, industrials, small cap, tariffs, value, volatility	The fund uses an intrinsic value approach to stock selection, seeking companies significantly undervalued on an absolute basis. The team believes the difference between market price and estimated intrinsic value of holdings was very attractive at month end, indicating above-average capital appreciation potential. Recent market volatility has provided opportunities to purchase new holdings and add to existing positions at attractive prices.		View
2026 Q1	Apr 20, 2026	Invesco Small Cap Value Fund	9.8%	9.8%	AAOI, BHE, CON, DAR, ERO, EXPE, ICHR, ICLR, LITE, MKSI, QDEL	Intrinsic Value, semiconductors, small caps, technology, undervalued, value			View
2024 Q1	Apr 15, 2024	Aristotle Small Cap Equity Fund	7.3%	9.4%	ACHC, AER, ASC, ASGN, ATNI, AZEK, CPLP, DY, HURN, ITRI, MATW, MCRB, MMSI, MODV, MTSI, PWSC, QDEL, SP	Construction, healthcare, industrials, small caps, technology, value	Manager remains optimistic about long-term potential for small cap segment despite strong recent performance. Valuations of small versus large cap equities remain near multi-decade lows with 16.0x P/E for Russell 2000 versus 21.8x for Russell 1000. Small caps are better positioned to benefit from reshoring of U.S. manufacturing, CHIPS Act, and infrastructure projects.	PWSC QDEL MODV ITRI AZEK	View
2024 Q1	Apr 15, 2024	Meridian Contrarian Fund	6.9%	0.0%	AXS, BEPC, CACI, CCJ, CRC, FCNCA, NVTS, PRGO, QDEL, SG, SGH, THC, VICI	contrarian, earnings, healthcare, semiconductors, small caps, technology, turnaround, value	Fund holds positions in semiconductor companies including Navitas Semiconductor Corp., which designs and produces highly efficient power semiconductors and leads in Gallium Nitride (GaN) technology. The company overcame significant technological hurdles to create competitive advantages in power efficiency and charging speeds over traditional silicon.	THC SG SGH NVTS BEPC QDEL	View
2024 Q1	Apr 15, 2024	Meridian Growth Fund	6.8%	0.0%	ACVA, ALIT, CARG, EEFT, IRDM, MATX, QDEL, RBA, SHC, ST, STE, TRMB, ZD	growth, Quality, Recurring Revenue, risk management, small caps, technology	QuidelOrtho Corporation is a global leader in the diagnostics industry following the merger of Quidel and Ortho Clinical Diagnostics. The company faced challenges from a dramatic slowdown in Covid-19 testing volumes but maintains steady performance in its core clinical diagnostic division with EBITDA margins north of 20%.	RBA ACVA TRMB SHC IRDM QDEL	View
2024 Q1	Apr 15, 2024	Meridian Small Cap Growth Fund	6.2%	0.0%	ACVA, ALIT, BYRN, CARG, CNCL, FORR, LZ, MATX, MIR, MMSI, NRGN, QDEL, RBA, SG, STNE, TPB	Automation, Diagnostics, growth, healthcare, small cap, technology	The fund holds multiple healthcare positions including QuidelOrtho Corporation in diagnostics, Consensus Cloud Solutions serving healthcare data security, and Neurogene in gene therapy. Healthcare IT staffing issues are creating macro pressure on enterprise-level adoptions.	SG NRGN BYRN FORR QDEL CNCL	View
2024 Q1	Mar 31, 2024	Baird Small/Mid Cap Growth Equity Fund	1.9%	1.9%	BOOT, BROS, BSY, BWXT, CELH, CHDN, CNMD, CWAN, DAVA, DECK, DT, EXAS, FIVE, FOUR, GLBE, GLOB, GXO, HALO, ICLR, INSP, KAI, KNSL, KNX, LFUS, LGIH, LSCC, LW, MNDY, MSTR, MTDR, ONTO, PCOR, PEN, PODD, QDEL, RGEN, SAM, SITM, SMCI, SMPL, SWAV, TARS, TECH, TREX, VITA, WNS, WSO, XPEL	AI, growth, healthcare, Performance, semiconductors, small cap, technology	AI spending expectations drove significant outperformance in technology stocks, particularly benefiting companies like Super Micro Computer which investors view as the next Nvidia. The fund has limited direct AI exposure through Lattice Semiconductor and has not reached comfort levels on sustainable AI impact for many benchmark holdings. AI headwinds affected both technology and industrial sectors as datacenter and semiconductor manufacturing equipment companies saw outsized gains.		View
2024 Q4	Feb 11, 2025	Invesco Small Cap Value Fund	4.3%	24.5%	AVTR, COHR, CSTM, EWBC, EXPE, GL, GTLS, HUN, ICLR, LITE, MSM, MXL, NRG, ONTO, QDEL, RMBS, TECK, VRT, VST, WAL, WBS	financials, industrials, Intrinsic Value, semiconductors, small cap, value	The fund employs an intrinsic value approach to select holdings, seeking companies significantly undervalued on an absolute basis. At quarter end, the difference between market prices and estimates of intrinsic value was attractive, indicating above-average long-term capital appreciation potential. The fund maintains a long-term investment horizon focused on wealth creation through undervalued opportunities.	MSM ONTO ICLR	View
2023 Q4	Dec 31, 2023	Meridian Small Cap Growth Fund	6.2%	0.0%	ALIT, CARG, CCCC, CCSI, EVRI, HDSN, MATX, MIR, QDEL, RBA, SKIN, SONX, TPB	Biotechnology, gaming, growth, healthcare, small cap, technology, value	The fund holds C4 Therapeutics, a biotechnology firm specializing in protein degradation therapies for cancer treatment. The company has three treatments in early-stage clinical trials targeting multiple cancers and announced a formal agreement with Merck for co-development. Positive clinical readout on a leading compound provided encouraging signals for therapeutic efficacy.	CCCC CARG MRAD	View
2024 Q3	Sep 30, 2024	Invesco Small Cap Value Fund	6.5%	19.5%	ATGE, BECN, COHR, EWBC, EXPE, GL, GTLS, HSIC, IART, LITE, MKSI, MTZ, MXL, NFE, NRG, QDEL, RMBS, SPB, VRT, VST, WAL, WBS	AI, healthcare, industrials, Intrinsic Value, Regional Banks, semiconductors, small cap, value	The fund uses an intrinsic value approach to select investments, seeking companies significantly undervalued on an absolute basis. At quarter end, the difference between market price and estimated intrinsic value of holdings was very attractive according to their estimation. Following outperformance of large-cap over small-cap in recent years, they see greater long-term upside to intrinsic value in many small-cap stocks compared to large-cap stocks.	QDEL RMBS BECN	View
2023 Q3	Sep 30, 2023	Meridian Small Cap Growth Fund	6.2%	0.0%	ALIT, ALKT, CCCS, HCCI, HDSN, MATX, MIR, QDEL, RBA, TPB	growth, healthcare, industrials, small caps, technology			View
2022 Q3	Sep 30, 2022	Alger Small Cap Focus Fund	6.4%	5.9%	HSKA, MRCY, NTRA, QDEL, RBC, SWAV	-			View

Pitches With This Ticker

Date	Pitch Type	Author	Company	Industry	Sub Industry	Bull / Bear	Stock Exchange	Keywords	Action
May 12, 2026	Fund Letters	McIntyre Partnerships	QuidelOrtho Corporation	Medical Devices	Health Care Equipment & Supplies	Bull	NASDAQ	Concentrated Position, diagnostics, Healthcare Equipment, Hospital Contracts, Life Sciences Tools, Medical devices, Point-of-Care Testing, Razor Razorblade Model, turnaround, Value	View Pitch
Apr 19, 2026	Seeking Alpha	Seeking Alpha	QuidelOrtho Corporation	Healthcare	Diagnostics & Research	Bull	NASDAQ Stock Market	2026 guidance, COVID-era revenues, debt management, Diagnostic Solutions, Free Cash Flow, In-vitro diagnostics, QuidelOrtho Corporation, recurring revenue, speculative buy, Turnaround strategy	View Pitch
Apr 13, 2026	Fund Letters	Meridian Contrarian Fund	QuidelOrtho Corp.	Health Care	Diagnostics & Research	Bull	NASDAQ	Free Cash Flow, government funding, Medical Diagnostics, Merger Synergies, New Leadership, Post-Pandemic Recovery, Respiratory Testing	View Pitch
Apr 13, 2026	Fund Letters	Aristotle Small Cap Equity Fund	QuidelOrtho	Health Care	Health Care Equipment & Supplies	Bull	NASDAQ	Healthcare Testing, In-vitro diagnostics, Medical devices, Point-of-Care Diagnostics, Product Diversification, Respiratory Diagnostics	View Pitch
Apr 13, 2026	Fund Letters	Meridian Contrarian Fund	QuidelOrtho Corp.	Health Care	Health Care Equipment	Bull	NASDAQ	COVID Testing, diagnostics, EBITDA margins, healthcare, In-vitro diagnostics, Medical devices, Point-of-care, product launch, Respiratory	View Pitch
Apr 13, 2026	Fund Letters	Meridian Growth Fund	QuidelOrtho Corporation	Health Care	Health Care Equipment	Neutral	NASDAQ	COVID-19, diagnostics, EBITDA, healthcare, In-vitro, Point-of-care, product launch, Respiratory	View Pitch
Apr 13, 2026	Fund Letters	Meridian Small Cap Growth Fund	QuidelOrtho Corporation	Health Care	Health Care Equipment	Bull	NASDAQ	Clinical Diagnostics, COVID Testing, diagnostics, Healthcare Equipment, Medical devices, Merger Integration, Point-of-Care Testing, product launch	View Pitch
Apr 13, 2026	Fund Letters	Invesco Small Cap Value Fund	QuidelOrtho	Health Care Equipment & Services	Health Care Equipment	Bull	NASDAQ	CEO transition, diagnostics, healthcare, Medical devices, operational efficiency, turnaround, Value	View Pitch
Jan 8, 2026	Fund Letters	James England	QuidelOrtho Corp.	Health Care	Diagnostics	Bull	NASDAQ	diagnostics, healthcare, recovery, Recurringrevenue, synergies	View Pitch
Oct 21, 2025	Value Investors Club	Novana	QuidelOrtho Corp.	Health Care	Health Care Supplies	Bull	NASDAQ	deleveraging, diagnostics, FCF inflection, Immunoassay, IVD, rerating	View Pitch

BSD Shareholders of QDEL

This report provides a detailed summary of investor holdings for a specified stock ticker, highlighting key metrics such as fund name, total assets under management (AUM), invested value, portfolio weight, and shares owned. It also tracks changes in share ownership during the last quarter, including the percentage of shares bought or sold and the percentage of outstanding shares owned. The data is generated using an API that processes investor holdings and calculates these values for each fund. This report helps investors and analysts monitor the stock positions of major funds, identify investment trends, and assess the influence of large investors on individual stocks.

Filing Date: September 30, 2025

Manager Name	Fund Name	Fund AUM	Invested Value	Portfolio Weight	Shares Owned	Shares Bought / Sold During Quarter	% Bought / Sold During Quarter	% of Shares Outstanding Owned
No investor data available.

QDEL

QDEL

Letters With This Ticker

Pitches With This Ticker

BSD Shareholders of QDEL

Join for free and get access to the buyside

Get insights from the world's most influential hedge fund investors direct to your inbox

Follow Us On: